Oral Estradiol Cost in Montana 2026

What Does Oral Estradiol Cost in Montana Right Now?

The average cash-pay price for a 30-day supply of generic oral estradiol at Montana retail pharmacies in 2026 is approximately $15. That is well below the $40 per month manufacturer list price. Prices vary by pharmacy chain, zip code, and dose, so comparing quotes across at least three dispensers before filling is worth the extra five minutes.

Generic 17-beta estradiol tablets are available in 0.5 mg, 1 mg, and 2 mg strengths. The FDA approved oral estradiol for moderate-to-severe vasomotor symptoms of menopause and for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian insufficiency. The full current prescribing information is maintained on the FDA's accessdata portal [1].

Estradiol belongs to the estrogen class of hormones. The Women's Health Initiative (WHI) trial published in JAMA in 2002 (N=16,608) remains one of the most referenced datasets on systemic estrogen therapy outcomes [2]. The North American Menopause Society (NAMS) 2022 Hormone Therapy Position Statement, published in the journal Menopause, states: "For women aged younger than 60 years or within 10 years of menopause onset and with no contraindications, the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms" [3]. That guidance directly supports why so many Montana women are seeking oral estradiol prescriptions.

Pricing at independent Montana pharmacies can differ noticeably from large chains. GoodRx, NeedyMeds, and pharmacy-specific loyalty programs frequently beat the standard retail price. A 1 mg tablet 30-count fill in Billings, Missoula, or Great Falls often lands between $10 and $18 cash-pay with a free discount card applied.

How Montana Medicaid Handles Oral Estradiol Coverage

Montana Medicaid does not currently cover oral estradiol for the treatment of moderate-to-severe vasomotor symptoms of menopause. This coverage gap affects a significant share of the state's lower-income female population enrolled in the Healthy Montana Kids Plus and Montana Medicaid programs.

Some exceptions exist. Medicaid may cover estradiol when prescribed for a diagnosis other than menopausal vasomotor symptoms, such as primary ovarian insufficiency or surgical menopause in younger patients. Each case requires prior authorization, and outcomes vary by the prescriber's documentation. The Montana Department of Public Health and Human Services administers the Medicaid preferred drug list, which is updated quarterly [4].

The Endocrine Society's 2015 clinical practice guideline on menopause hormone therapy recommends treatment for women with significant symptoms and favorable risk profiles, specifically noting that younger surgical menopause patients have a stronger indication [5]. When a Montana Medicaid patient meets that profile, a well-documented prior authorization request citing the Endocrine Society guideline has a higher likelihood of approval than a generic request.

Patients on Medicare Part D should check their specific plan formulary. Most Part D plans place generic estradiol on Tier 1 or Tier 2, meaning a 30-day supply may cost $0 to $10 with standard cost-sharing. The CMS formulary finder tool at cms.gov allows Montana residents to compare plan-level estradiol coverage before the annual enrollment window [6].

Is Compounded Oral Estradiol Legal in Montana?

Yes. Compounded oral estradiol is legal in Montana when prepared by a 503A-licensed compounding pharmacy operating under a valid prescription from a licensed prescriber. Some Montana patients pay $0 per month for compounded estradiol through specific pharmacy programs tied to telehealth platforms.

The FDA distinguishes 503A pharmacies (patient-specific compounding, state-regulated) from 503B outsourcing facilities (larger-scale, federally registered). For individual patients, 503A is the relevant pathway. The FDA's current guidance on compounding is available at fda.gov [7]. Montana's Board of Pharmacy oversees 503A compliance at the state level and maintains a license lookup tool for residents to verify a compounding pharmacy's standing [8].

Compounded estradiol is not FDA-approved as a finished drug product. The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 141 notes that compounded hormones lack the rigorous efficacy and safety data that approved products carry [9]. Patients choosing compounded estradiol should discuss the trade-offs with their prescriber, including the absence of standardized bioavailability data across compounding lots.

A 2019 study in Menopause (PMID 30339571) found measurable variability in hormone concentrations across compounded estradiol preparations from different pharmacies [10]. That variability does not mean compounded products are unsafe, but it means monitoring estradiol serum levels is more important when using compounded formulations than when using an FDA-approved generic tablet.

Can Montana Residents Get Oral Estradiol Through Telehealth?

Telehealth prescribing of oral estradiol is fully legal in Montana. A licensed Montana prescriber can evaluate a patient via synchronous audio-video visit and issue a valid oral estradiol prescription, which can then be filled at any Montana pharmacy or mailed from an out-of-state pharmacy licensed in Montana.

Montana enacted SB 101 (2021), which expanded telehealth parity requirements for insurers, meaning most commercial plans must cover telehealth visits at the same rate as in-person visits for qualifying services [11]. Hormone replacement evaluation generally qualifies. The visit cost itself varies: cash-pay telehealth consultations for hormone therapy typically run $75 to $150 for an initial visit on most platforms, with follow-ups at $45 to $75.

The Federation of State Medical Boards has published model policy guidance on telemedicine prescribing that Montana's Medical Board references [12]. A prescriber must conduct an adequate evaluation, including a review of medical history and contraindications, before issuing a hormone therapy prescription via telehealth. A prescriber cannot issue estradiol based on a patient questionnaire alone without a live synchronous encounter.

Patients in rural Montana counties, including Petroleum, Carter, and Treasure counties, where the nearest OB-GYN or endocrinologist may be over 100 miles away, benefit most from telehealth access. The Health Resources and Services Administration (HRSA) designates a large portion of rural Montana as a Health Professional Shortage Area [13]. Telehealth closes that geographic gap without requiring a full day of travel.

Which Insurance Plans Cover Oral Estradiol in Montana?

Most commercial insurance plans sold in Montana cover generic oral estradiol, typically on Tier 1 or Tier 2 of the formulary. Tier 1 generics usually cost $0 to $15 per 30-day fill with standard cost-sharing. The exact tier depends on the insurer and the specific plan year.

Montana's individual and small-group market plans sold through the federal marketplace (healthcare.gov) are required under the Affordable Care Act to cover preventive services rated A or B by the U.S. Preventive Services Task Force. The USPSTF recommends against using combined hormone therapy to prevent chronic conditions in postmenopausal women, but that recommendation does not restrict coverage of hormone therapy for symptomatic treatment [14]. Treatment for vasomotor symptoms is a separate clinical indication and is covered as a prescription drug benefit on most formularies.

Blue Cross Blue Shield of Montana, Montana Health CO-OP, and PacificSource are among the carriers offering plans in the MT individual market. Each publishes a formulary document searchable by drug name. Patients should look up "estradiol tablet" or the specific NDC number on their carrier's formulary tool before assuming coverage.

Employer-sponsored self-insured plans (ERISA plans) are governed by federal law, not Montana state insurance law. Those plans set their own formularies, and coverage of estradiol varies. An HR benefits administrator or plan summary plan description will confirm the tier placement.

A 2021 analysis in JAMA Internal Medicine found that hormone therapy for menopausal symptoms was covered by 86% of surveyed commercial formularies, though out-of-pocket costs varied by up to 12-fold across plans [15]. That spread is meaningful for a Montana resident comparing plan options during open enrollment.

What Discount Programs Reduce Oral Estradiol Costs in Montana?

Several discount pathways bring oral estradiol costs below the already-low $15 per month cash-pay baseline in Montana. GoodRx, RxSaver, and NeedyMeds all offer free printable or digital coupons accepted at most Montana pharmacies. In many cases these coupons price a 1 mg tablet 30-count fill at $8 to $12.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic estradiol at under $5 for a 30-day supply plus a small dispensing fee, with mailing available to Montana addresses. That platform requires a valid prescription and ships from a licensed pharmacy. The National Library of Medicine's DailyMed database confirms the approved labeling details for estradiol tablet formulations [16].

Manufacturer patient assistance programs (PAPs) apply primarily to branded products such as Estrace. Pfizer and other manufacturers maintain PAPs for patients who meet income thresholds, typically under 200% to 400% of the federal poverty level. The NeedyMeds database at needymeds.org lists current Montana-accessible PAPs [17].

The HRSA Health Center program funds federally qualified health centers (FQHCs) across Montana, including clinics in Billings, Helena, and Missoula. FQHCs use the 340B drug pricing program, which allows them to purchase estradiol at significantly reduced cost and pass those savings to uninsured or underinsured patients [18]. A patient without insurance who establishes care at an FQHC may pay $0 to $5 for an estradiol prescription filled through the center's in-house or contract pharmacy.

State pharmaceutical assistance is limited in Montana. Unlike some states, Montana does not operate a state-funded senior drug assistance program that specifically covers estradiol. The Montana State Pharmaceutical Assistance Program page at dphhs.mt.gov should be checked periodically, as legislation can change program scope [19].

Understanding the Clinical Evidence Behind Oral Estradiol Dosing

Oral estradiol at doses of 0.5 mg to 2 mg daily is the most studied formulation for vasomotor symptom relief. The WISDOM trial and multiple Cochrane systematic reviews have evaluated oral estrogen's efficacy profile. A 2015 Cochrane review by Marjoribanks et al. (PMID 26171909) covering 24 trials found that oral estrogen therapy reduced hot flush frequency by approximately 75% compared to placebo [20].

The WHI trial (JAMA 2002, N=16,608) studied conjugated equine estrogen 0.625 mg, not 17-beta estradiol specifically, and its findings are not directly transferable to lower-dose 17-beta estradiol without careful interpretation [2]. The KEEPS trial (Kronos Early Estrogen Prevention Study) compared oral conjugated equine estrogen 0.45 mg to transdermal estradiol 50 mcg in recently menopausal women over 4 years and found that oral estradiol had a more pronounced effect on LDL reduction but also raised triglycerides more than the transdermal route [21].

Oral estradiol undergoes first-pass hepatic metabolism, converting substantially to estrone. That metabolic difference from transdermal routes is pharmacologically meaningful. A review in Climacteric (PMID 24754291) noted that oral administration produces estrone-to-estradiol ratios of approximately 5:1, while transdermal delivery produces ratios closer to 1:1 [22]. For most healthy women under 60 seeking vasomotor symptom relief, this distinction may not change clinical outcomes, but it is relevant for women with elevated triglycerides, clotting risk, or prior venous thromboembolism, where transdermal routes are generally preferred per NAMS guidance [3].

Dose titration matters. Starting at 0.5 mg daily and increasing to 1 mg at 4 to 8 weeks based on symptom response and serum estradiol levels is a common clinical approach. The target serum estradiol level for symptom relief generally falls between 40 and 100 pg/mL, though individual thresholds vary. The Endocrine Society guideline [5] and NAMS position statement [3] both support using the lowest effective dose for the shortest duration consistent with treatment goals.

Women with an intact uterus require concurrent progestogen therapy to prevent endometrial hyperplasia. The PEPI trial (JAMA 1996, N=875) demonstrated that unopposed estrogen significantly increased endometrial hyperplasia rates over 3 years compared to combined estrogen-progestogen regimens [23]. Montana prescribers routinely add micronized progesterone 100 to 200 mg nightly or a low-dose progestogen to any oral estradiol regimen in women who have not had a hysterectomy.

How Oral Estradiol Compares to Other Estrogen Delivery Routes on Cost in Montana

Oral tablets are generally the least expensive estradiol option in Montana. Transdermal patches (Vivelle-Dot, Climara generics) cost roughly $20 to $35 per month cash-pay in Montana. Estradiol gel (EstroGel, Divigel) runs $30 to $60 per month. Vaginal estradiol inserts (Vagifem, Yuvafem) are targeted for genitourinary symptoms rather than systemic vasomotor relief and cost $25 to $55 monthly.

For purely cost-driven decisions, oral generic tablets at $8 to $15 with a discount card represent the lowest barrier to access. A comparative pharmacoeconomic analysis published in the American Journal of Managed Care found that oral estrogen formulations consistently carried lower pharmacy costs than patch or gel equivalents across all U.S. payer types [24]. That cost advantage is amplified in Montana, where fewer large pharmacy chains compete and negotiated prices may be less aggressive than in urban states.

The clinical choice of route, however, should not be driven by cost alone. Venous thromboembolism risk, triglyceride levels, patient adherence preferences, and skin sensitivity all inform route selection. The 2019 NICE guideline on menopause (NG23) recommends transdermal estradiol as the preferred route for women at elevated VTE risk, noting that oral estrogen is associated with a two- to four-fold increase in VTE risk compared to transdermal [25].

Montana-Specific Resources for Oral Estradiol Access

Montana has 56 counties covering nearly 150,000 square miles. Pharmacy access is uneven. The Montana Pharmacy Association (MPA) maintains a directory of independent pharmacies across the state, many of which accept GoodRx coupons and can order any commercially available generic estradiol tablet within 24 to 48 hours. Rural patients can also use mail-order pharmacies affiliated with their insurance plan, which frequently offer 90-day supplies at two times the 30-day copay, effectively delivering a free month per quarter.

The Indian Health Service (IHS) operates facilities serving Montana's tribal nations, including the Crow, Northern Cheyenne, Fort Belknap, Fort Peck, Blackfeet, Salish and Kootenai, and Little Shell communities. IHS pharmacies can dispense estradiol to eligible Native American beneficiaries at no cost under the IHS formulary [26]. Tribal members who receive care through an IHS or tribal health facility should confirm estradiol's formulary status with their facility pharmacist.

Planned Parenthood of Montana and the Montana Primary Care Association's member FQHCs also provide hormonal care, including HRT prescribing, on sliding-scale fees for uninsured patients. These organizations can serve as both prescriber and dispenser access points for patients who cannot afford the telehealth plus pharmacy cost combination.